Article · 29 Aug 2026
Conference abstract
Past, present, and augmentation of current vaccines for select category A/B pathogens
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
E vents in the last several decades have brought into focus the need for preventive countermeasures against the possible exposure to biological agents that impact not only the physical state of the individual but imparts a lasting psychological fear in the general population. More recent events have demonstrated how easily one biological agent was used to aff ect our lives and has been part of an initiative to re-examine what type of countermeasures can best be used to protect us aft er exposure to a biological agent. With the possibility of the appearance of a newly genetically engineered biological agent or unexpected spread of an obscure emerging pa tho- gen, it may take a multidisciplinary approach to control the immediate and long-term consequences of the pathogen. Whether it i s important to emphasize the development of prophylactic countermeasures, postexposure therapeutics, new diagnostic identifi cation procedures or rely on all three avenues for better protection against biological agents might be debatable; nevertheless, proph ylaxis vaccination has been successfully used against many infectious diseases acquired by humans. We will present the current status of vaccines against select Category A/B bacterial pathogens ( Bacillus anthracis, Yersinia pestis, Francisella tularensis, Burkholderia mallei, and B. pseudomallei ), what type of platforms and adjuvants are being used, what possible future candidate vaccines are be- ing considered, and what animal models are being used to measure effi cacy of the vaccine. In addition, because of an increase in the understanding of the host response to infectious biological agents, specifi cally how the innate immune response can directly aff ect the acquired immune response, we can use this information to augment the immune response of the host to candidate vaccines. Some examples of how stimulation of the innate immune response to the vaccine increases their effi cacy will be presented
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Kei Amemiya”